The Environmental Protection Agency published its final rule on Friday.
The Environmental Protection Agency (EPA; Washington, DC) today published a final rule to remove saccharin (and its salts) from two federal lists for hazardous waste substances.
The ingredient is now clear from hazard substance lists in both the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation, and Liability Act, both of which are federal legislation intended to facilitate cleanup of hazardous waste.
Saccharin is used as an artificial sweetener in products ranging from juices, soft drinks, and candies to cosmetics and pharmaceuticals. The substance has dealt with a history of ties to adverse health effects, according to NPR news, who reports that research has even linked its consumption to cancer in rats.
Saccharin’s regained image was influenced by a petition to the EPA from the Calorie Control Council, a non-profit organization representing the low calorie food and beverage industry.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.